We’re working to invent a world where cancer isn’t just treated, but cured.
Our mission is to deliver breakthrough innovations that extend and improve the lives of people with cancer
We work to prevent cancer through preventive vaccination and to provide oncologists with treatment options that give their patients a better quality of life and more time.
Everyone knows someone who has been touched by cancer. When a cancer diagnosis happens, what matters most isn’t what the next scientific breakthrough is – but when it will be available to patients in Switzerland.
Our work in oncology
clinical trials involving our cancer medicines in Switzerland (as of 11/2021).
patients currently enrolled in our clinical trials in Switzerland and round about 250 patients are actively on study drug (as of 11/2021).
different types of cancer are being studied in our clinical trials Switzerland (as of 11/2021).
Our company has a long history of bringing forward innovative medicines. In the field of oncology, we focus on immunotherapy, which aims to activate the body's own immune system to fight the tumor. Our relentless commitment to research and development has enabled us to establish an exceptionally broad research program with more than 1'600 studies. Switzerland is part of this program, currently conducting 31 clinical trials in 11 different tumor types (as of 11/2021). Today, our portfolio includes oncology medicines that treat different cancers and conditions related to cancer treatment.
Access to care
Improving access to cancer care is our strategic priority. We are working with the entire cancer community to help patients gain access to the oncology medicines that they need and to expand the provision of quality cancer care.
The Swiss Oncology team is
- collaborating with authorities and institutions to ensure access to our medicines
- working on solutions how to continuously improve the support of healthcare professionals and patients in the treatment of cancer
- interacting with Oncologists, Scientific leaders and patient organizations to gain insight into market and customer needs.
Progress through partnerships
We work with the entire cancer community - advocacy partners, health care providers, government and industry colleagues - all who share our mission to extend and improve the lives of people with cancer.
Our team has engaged in collaborative efforts to raise the awareness of cancer and improve its prevention, including the creation of regular platforms for stakeholder to advance health policy discussions around cancer care. Furthermore we are a founding member of the multi-stakeholder alliance “All.Can” which aims to exploit efficiency in cancer care.
We participate in several initiatives to support patients with cancer. These include:
- a website for disease management
- campaigns to educate the public about early signs and detection
- a partnership to improve sustainable cancer care all-can.org.
Key therapeutic areas
MSD is one of the world 's leading companies in oncology. Visionary research and collaborative action have already led to breakthroughs for the prevention and treatment of certain types of cancer and we're committed to driving further innovation to help change the future of this disease.
Business Unit Director Oncology · MSD Switzerland
It takes all of us to beat cancer
As long as doctors are desperate to add years to the lives of their patients, and a world where treatments aren’t accessible to all, we will be here: fighting with all we have to deliver more, sooner.
What is breast cancer?
Breast cancer is a malignant tumor in the breast that mainly affects women. How the disease develops depends on various factors. Breast cancer treatment can be highly effective, particularly when the disease is identified early. On this page, you can learn more about the different types, symptoms, diagnosis, risk factors and prevention, as well as treatment options.
Cervical cancer – what you should know
Cervical cancer is a rather rare disease in Switzerland. It can be cured if diagnosed at an early stage and managed effectively. Most cases of cervical cancer can be prevented by HPV vaccination and other preventive measures like screening for, and treating precancerous lesions. Learn more here.
Taking on lung cancer is worth the fight
Lung cancer is the most commonly diagnosed cancer worldwide, and more than 4'000 people die of the disease every day.
Clinical studies are the key to gaining new knowledge about the diagnosis and treatment of diseases.
We’re proud to be contributing to this effort in Switzerland.
The ongoing clinical study program in Switzerland includes 31 studies in various cancers (as of 11/2021).